Kura Oncology, Inc.
US ˙ NasdaqGS ˙ US50127T1097

Introduction

This page provides a comprehensive analysis of the known insider trading history of Steven H Stein. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Steven H Stein has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:INCY / Incyte Corporation EVP & Chief Medical Officer 102,886
US:KURA / Kura Oncology, Inc. Director 23,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Steven H Stein. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases KURA / Kura Oncology, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in KURA / Kura Oncology, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

KURA / Kura Oncology, Inc. Insider Trades
Insider Sales KURA / Kura Oncology, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in KURA / Kura Oncology, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

KURA / Kura Oncology, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Steven H Stein as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-07-23 2025-07-21 4 INCY INCYTE CORP
Common Stock
S - Sale -3,706 102,886 -3.48 67.94 -251,786 6,990,075
2025-07-16 2025-07-15 4 INCY INCYTE CORP
Common Stock
A - Award 12,277 106,592 13.02
2025-07-16 2025-07-15 4 INCY INCYTE CORP
Common Stock
F - Taxes -1,596 94,315 -1.66 68.25 -108,927 6,436,999
2025-07-16 2025-07-14 4 INCY INCYTE CORP
Common Stock
F - Taxes -1,555 95,911 -1.60 69.98 -108,819 6,711,852
2025-07-16 2025-07-14 4 INCY INCYTE CORP
Common Stock
S - Sale -14,952 97,466 -13.30 68.47 -1,023,763 6,673,497
2025-07-07 2025-07-02 4 INCY INCYTE CORP
Common Stock
F - Taxes -12,714 112,418 -10.16 68.17 -866,713 7,663,535
2025-04-03 2025-04-01 4 INCY INCYTE CORP
Common Stock
A - Award 20,967 125,132 20.13
2025-04-03 2025-04-01 4 INCY INCYTE CORP
Common Stock
A - Award 37,198 104,165 55.55
2025-01-22 2025-01-21 4 INCY INCYTE CORP
Common Stock
S - Sale -12,352 66,967 -15.57 72.69 -897,867 4,867,831
2025-01-17 2025-01-15 4 INCY INCYTE CORP
Common Stock
F - Taxes -10,692 79,319 -11.88 72.46 -774,742 5,747,455
2024-08-14 2024-08-12 4 INCY INCYTE CORP
Common Stock
S - Sale -11,608 90,011 -11.42 60.63 -703,793 5,457,367
2024-07-17 2024-07-15 4 INCY INCYTE CORP
Common Stock
F - Taxes -1,555 101,619 -1.51 64.25 -99,909 6,529,021
2024-07-17 2024-07-15 4 INCY INCYTE CORP
Common Stock
A - Award 13,895 103,174 15.56
2024-07-03 2024-07-02 4 INCY INCYTE CORP
Common Stock
F - Taxes -8,316 89,279 -8.52 59.02 -490,810 5,269,247
2024-02-16 2024-02-14 4 INCY INCYTE CORP
Common Stock
A - Award 7,377 97,595 8.18
2024-01-05 2024-01-03 4 INCY INCYTE CORP
Common Stock
S - Sale -7,365 90,218 -7.55 65.51 -482,481 5,910,181
2023-08-03 2023-08-01 4 INCY INCYTE CORP
Common Stock
S - Sale -21,511 97,583 -18.06 63.28 -1,361,216 6,175,052
2023-07-18 2023-07-14 4 INCY INCYTE CORP
Common Stock
A - Award 13,535 119,094 12.82
2023-07-06 2023-07-03 4 INCY INCYTE CORP
Common Stock
F - Taxes -8,442 105,559 -7.41 62.08 -524,079 6,553,103
2023-01-24 2023-01-20 4 INCY INCYTE CORP
Common Stock
A - Award 4,980 114,001 4.57
2023-01-06 2023-01-04 4 INCY INCYTE CORP
Common Stock
S - Sale X -28,399 109,021 -20.67 79.78 -2,265,672 8,697,695
2022-07-06 2022-07-05 4 INCY INCYTE CORP
Common Stock
F - Taxes -3,856 137,420 -2.73 79.25 -305,588 10,890,535
2022-07-06 2022-07-02 4 INCY INCYTE CORP
Common Stock
A - Award 18,941 141,276 15.48
2022-06-30 2022-06-28 4 INCY INCYTE CORP
Common Stock
F - Taxes -11,488 122,335 -8.58 75.63 -868,837 9,252,196
2022-01-21 2022-01-19 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 15,054 15,054
2022-01-05 2022-01-01 4 INCY INCYTE CORP
Common Stock
A - Award 28,926 133,823 27.58
2021-11-23 2021-11-19 4 INCY INCYTE CORP
Common Stock
A - Award 2,355 104,897 2.30
2021-11-23 2021-11-19 4 INCY INCYTE CORP
Common Stock
A - Award 379 102,542 0.37
2021-07-07 2021-07-06 4 INCY INCYTE CORP
Common Stock
F - Taxes -402 102,163 -0.39 83.34 -33,503 8,514,264
2021-07-07 2021-07-02 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 15,054 15,054
2021-07-07 2021-07-02 4 INCY INCYTE CORP
Common Stock
F - Taxes -2,953 102,565 -2.80 83.58 -246,812 8,572,383
2021-07-07 2021-07-02 4 INCY INCYTE CORP
Common Stock
A - Award 7,853 105,518 8.04
2021-06-30 2021-06-28 4 INCY INCYTE CORP
Common Stock
F - Taxes -22,079 97,665 -18.44 85.61 -1,890,183 8,361,101
2021-06-23 2021-06-22 4 KURA Kura Oncology, Inc.
Option to purchase common stock
A - Award 23,000 23,000
2021-01-27 2021-01-25 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -3,795 8,539 -30.77
2021-01-27 2021-01-25 4 INCY INCYTE CORP
Common Stock
S - Sale -3,795 119,744 -3.07 100.00 -379,500 11,974,400
2021-01-27 2021-01-25 4 INCY INCYTE CORP
Common Stock
M - Exercise 3,795 123,539 3.17 68.62 260,413 8,477,246
2021-01-20 2021-01-15 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 12,743 12,743
2021-01-20 2021-01-15 4 INCY INCYTE CORP
Common Stock
A - Award 23,044 119,744 23.83
2020-11-18 2020-11-16 4 INCY INCYTE CORP
Common Stock
A - Award 1,232 96,700 1.29
2020-07-17 2020-07-16 4 INCY INCYTE CORP
Common Stock
S - Sale -766 95,468 -0.80 103.83 -79,534 9,912,442
2020-07-17 2020-07-15 4 INCY INCYTE CORP
Common Stock
F - Taxes -623 96,234 -0.64 104.25 -64,948 10,032,394
2020-07-08 2020-07-08 4 INCY INCYTE CORP
Common Stock
S - Sale -610 96,857 -0.63 108.56 -66,222 10,514,796
2020-07-08 2020-07-07 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -7,495 0 -100.00
2020-07-08 2020-07-07 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -3,381 0 -100.00
2020-07-08 2020-07-07 4 INCY INCYTE CORP
Common Stock
S - Sale -3,283 97,467 -3.26 107.99 -354,531 10,525,461
2020-07-08 2020-07-07 4 INCY INCYTE CORP
Common Stock
S - Sale -7,495 100,750 -6.92 110.04 -824,750 11,086,530
2020-07-08 2020-07-07 4 INCY INCYTE CORP
Common Stock
M - Exercise 7,495 108,245 7.44 88.68 664,657 9,599,167
2020-07-08 2020-07-07 4 INCY INCYTE CORP
Common Stock
S - Sale -3,381 100,750 -3.25 110.04 -372,045 11,086,530
2020-07-08 2020-07-07 4 INCY INCYTE CORP
Common Stock
M - Exercise 3,381 104,131 3.36 88.68 299,827 9,234,337
2020-07-07 2020-07-06 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -10,437 12,334 -45.83
2020-07-07 2020-07-06 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -10,437 12,334 -45.83
2020-07-07 2020-07-06 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -12,132 1,194 -91.04
2020-07-07 2020-07-06 4 INCY INCYTE CORP
Incentive Stock Option (right to buy)
M - Exercise -596 0 -100.00
2020-07-07 2020-07-06 4 INCY INCYTE CORP
Common Stock
S - Sale -10,437 100,750 -9.39 107.31 -1,119,994 10,811,482
2020-07-07 2020-07-06 4 INCY INCYTE CORP
Common Stock
S - Sale -10,437 100,750 -9.39 107.31 -1,119,994 10,811,482
2020-07-07 2020-07-06 4 INCY INCYTE CORP
Common Stock
M - Exercise 10,437 111,187 10.36 68.62 716,187 7,629,652
2020-07-07 2020-07-06 4 INCY INCYTE CORP
Common Stock
M - Exercise 10,437 111,187 10.36 72.27 754,282 8,035,484
2020-07-07 2020-07-06 4 INCY INCYTE CORP
Common Stock
S - Sale -12,132 100,750 -10.75 107.31 -1,301,885 10,811,482
2020-07-07 2020-07-06 4 INCY INCYTE CORP
Common Stock
M - Exercise 12,132 112,882 12.04 83.83 1,017,026 9,462,898
2020-07-07 2020-07-06 4 INCY INCYTE CORP
Common Stock
S - Sale -596 100,750 -0.59 107.31 -63,957 10,811,482
2020-07-07 2020-07-06 4 INCY INCYTE CORP
Common Stock
M - Exercise 596 101,346 0.59 83.83 49,963 8,495,835
2020-07-07 2020-07-06 4 INCY INCYTE CORP
Common Stock
S - Sale -2,522 100,750 -2.44 106.40 -268,341 10,719,800
2020-07-07 2020-07-06 4 INCY INCYTE CORP
Common Stock
F - Taxes -269 103,272 -0.26 107.79 -28,996 11,131,689
2020-07-07 2020-07-02 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 12,743 12,743
2020-07-07 2020-07-02 4 INCY INCYTE CORP
Common Stock
F - Taxes -1,474 103,541 -1.40 106.47 -156,937 11,024,010
2020-07-07 2020-07-02 4 INCY INCYTE CORP
Common Stock
A - Award 6,661 105,015 6.77
2020-06-26 2020-06-24 4 KURA Kura Oncology, Inc.
Option to purchase common stock
A - Award 23,000 23,000
2020-06-22 2020-06-18 4 INCY INCYTE CORP
Common Stock
A - Award 25,000 98,354 34.08
2020-02-18 2020-02-13 4 INCY INCYTE CORP
Common Stock
A - Award 6,881 73,354 10.35
2020-01-22 2020-01-17 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 16,428 16,428
2019-10-31 2019-10-30 4 INCY INCYTE CORP
Common Stock
A - Award 50,000 66,473 303.53
2019-07-16 2019-07-15 4 INCY INCYTE CORP
Common Stock
F - Taxes -409 16,473 -2.42 81.39 -33,289 1,340,737
2019-07-09 2019-07-05 4 INCY INCYTE CORP
Common Stock
F - Taxes -267 16,882 -1.56 85.28 -22,770 1,439,697
2019-07-03 2019-07-02 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 16,428 16,428
2019-07-03 2019-07-02 4 INCY INCYTE CORP
Common Stock
F - Taxes -417 17,149 -2.37 85.01 -35,449 1,457,836
2019-07-03 2019-07-02 4 INCY INCYTE CORP
Common Stock
A - Award 6,761 17,566 62.57
2019-06-27 2019-06-25 4 KURA Kura Oncology, Inc.
Option to purchase common stock
A - Award 13,000 13,000
2019-06-25 2019-06-24 4 INCY INCYTE CORP
Common Stock
S - Sale -8,357 10,805 -43.61 87.96 -735,082 950,408
2019-02-19 2019-02-14 4 INCY INCYTE CORP
Common Stock
A - Award 5,389 19,162 39.13
2019-01-08 2019-01-07 4 INCY INCYTE CORP
Common Stock
F - Taxes -847 13,773 -5.79 74.21 -62,856 1,022,094
2019-01-08 2019-01-04 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 22,772 22,772
2018-07-18 2018-07-16 4 INCY INCYTE CORP
Common Stock
F - Taxes -577 14,620 -3.80 70.19 -40,500 1,026,178
2018-07-05 2018-07-05 4 INCY INCYTE CORP
Common Stock
F - Taxes -262 15,197 -1.69 68.28 -17,889 1,037,651
2018-07-05 2018-07-02 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 22,772 22,772
2018-06-08 2018-06-07 4 KURA Kura Oncology, Inc.
Option to purchase common stock
A - Award 13,000 13,000
2018-03-06 2018-03-02 4 INCY INCYTE CORP
Common Stock
F - Taxes -2,081 15,459 -11.86 86.61 -180,235 1,338,904
2018-01-25 2018-01-24 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 21,167 21,167
2018-01-25 2018-01-23 4 INCY INCYTE CORP
Employee Stock Option (right to buy)
A - Award 12,128 12,128
2017-09-15 2017-09-13 4 INCY INCYTE CORP
Common Stock
F - Taxes -625 17,540 -3.44 123.15 -76,969 2,160,051
2017-08-31 2017-08-29 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -397 13,326 -2.89
2017-08-31 2017-08-29 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -1,192 7,495 -13.72
2017-08-31 2017-08-29 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -522 8,348 -5.89
2017-08-31 2017-08-29 4 INCY INCYTE CORP
Common Stock
S - Sale -397 18,165 -2.14 125.00 -49,625 2,270,625
2017-08-31 2017-08-29 4 INCY INCYTE CORP
Common Stock
S - Sale -1,192 18,562 -6.03 125.00 -149,000 2,320,250
2017-08-31 2017-08-29 4 INCY INCYTE CORP
Common Stock
S - Sale -522 19,754 -2.57 125.00 -65,250 2,469,250
2017-08-31 2017-08-29 4 INCY INCYTE CORP
Common Stock
M - Exercise 397 20,276 2.00 83.83 33,281 1,699,737
2017-08-31 2017-08-29 4 INCY INCYTE CORP
Common Stock
M - Exercise 1,192 19,879 6.38 88.68 105,707 1,762,870
2017-08-31 2017-08-29 4 INCY INCYTE CORP
Common Stock
M - Exercise 522 18,687 2.87 95.76 49,987 1,789,467
2017-07-21 2017-07-20 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -522 8,870 -5.56
2017-07-21 2017-07-20 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -4,772 13,723 -25.80
2017-07-21 2017-07-20 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -1,191 8,687 -12.06
2017-07-21 2017-07-20 4 INCY INCYTE CORP
Common Stock
S - Sale -522 18,165 -2.79 131.09 -68,429 2,381,250
2017-07-21 2017-07-20 4 INCY INCYTE CORP
Common Stock
S - Sale -4,772 18,687 -20.34 131.09 -625,561 2,449,679
2017-07-21 2017-07-20 4 INCY INCYTE CORP
Common Stock
S - Sale -1,191 23,459 -4.83 131.09 -156,128 3,075,240
2017-07-21 2017-07-20 4 INCY INCYTE CORP
Common Stock
M - Exercise 522 24,650 2.16 95.76 49,987 2,360,484
2017-07-21 2017-07-20 4 INCY INCYTE CORP
Common Stock
M - Exercise 4,772 24,128 24.65 83.83 400,037 2,022,650
2017-07-21 2017-07-20 4 INCY INCYTE CORP
Common Stock
M - Exercise 1,191 19,356 6.56 88.68 105,618 1,716,490
2017-07-07 2017-07-05 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 12,128 12,128
2017-07-07 2017-07-05 4 INCY INCYTE CORP
Common Stock
A - Award 3,517 18,165 24.01
2017-06-22 2017-06-20 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -6,013 9,878 -37.84
2017-06-22 2017-06-20 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -3,870 9,392 -29.18
2017-06-22 2017-06-20 4 INCY INCYTE CORP
Common Stock
S - Sale -6,013 14,648 -29.10 125.00 -751,625 1,831,000
2017-06-22 2017-06-20 4 INCY INCYTE CORP
Common Stock
S - Sale -3,870 20,661 -15.78 125.00 -483,750 2,582,625
2017-06-22 2017-06-20 4 INCY INCYTE CORP
Common Stock
M - Exercise 6,013 24,531 32.47 88.68 533,233 2,175,409
2017-06-22 2017-06-20 4 INCY INCYTE CORP
Common Stock
M - Exercise 3,870 18,518 26.42 95.76 370,591 1,773,284
2017-06-12 2017-06-09 4 KURA Kura Oncology, Inc.
Option to purchase common stock
A - Award 10,000 10,000
2017-04-11 2017-04-07 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -5,000 13,262 -27.38
2017-04-11 2017-04-07 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -27,000 15,891 -62.95
2017-04-11 2017-04-07 4 INCY INCYTE CORP
Common Stock
S - Sale -5,000 14,648 -25.45 137.91 -689,550 2,020,106
2017-04-11 2017-04-07 4 INCY INCYTE CORP
Common Stock
S - Sale -27,000 19,648 -57.88 137.88 -3,722,760 2,709,066
2017-04-11 2017-04-07 4 INCY INCYTE CORP
Common Stock
M - Exercise 5,000 46,648 12.01 95.76 478,800 4,467,012
2017-04-11 2017-04-07 4 INCY INCYTE CORP
Common Stock
M - Exercise 27,000 41,648 184.33 88.68 2,394,360 3,693,345
2017-01-19 2017-01-17 4 INCY INCYTE CORP
Inventive Stock Option (right to buy)
A - Award 879 879
2017-01-19 2017-01-17 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 17,986 17,986
2017-01-19 2017-01-17 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 19,091 19,091
2017-01-03 2017-01-03 4 KURA Kura Oncology, Inc.
Option to purchase common stock
A - Award 3,333 3,333
2017-01-03 2017-01-03 4 KURA Kura Oncology, Inc.
Option to purchase common stock
A - Award 30,000 30,000
2016-07-19 2016-07-15 4 INCY INCYTE CORP
Inventive Stock Option (right to buy)
A - Award 596 596
2016-07-19 2016-07-15 4 INCY INCYTE CORP
Non-Qualified Stock Option (right to buy)
A - Award 18,495 18,495
2016-07-19 2016-07-15 4 INCY INCYTE CORP
Common Stock
A - Award 5,555 14,648 61.09
2016-05-11 3 INCY INCYTE CORP
Common Stock
18,186
2016-05-11 3 INCY INCYTE CORP
Common Stock
18,186
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)